NOT-DK-25-003: Notice of NIDDK Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice of NIDDK Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice Number:

NOT-DK-25-003

Key Dates

Release Date:

October 8, 2024

Related Announcements

October 2, 2024 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See NOFO PA-25-080.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to inform potential applicants that effective immediately the National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK) will participate in PA-25-080 “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)” issued by the National Institutes of Health.

The following text (in italics) has been added to reflect NIDDK's participation:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.847

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

For inquiries, please email NIDDK-R13@niddk.nih.gov.

For information about funding R13s, please see https://www.niddk.nih.gov/research-funding/process/apply/funding-mechanisms/r13